We aimed to evaluate the influence of urological complications occurring within the first year after kidney transplantation on long-term patient and graft outcomes, and sought to examine the impact of the management approach of ureteral strictures on long-term graft function. We collected data on urological complications occurring within the first year posttransplant. Graft survivals, patient survival, and rejection rates were compared between recipients with and without urological complications.
Male gender of the recipient, delayed graft function, and donor age were found to be significant risk factors for urological complications after kidney transplantation (P < .05). Death censored graft survival analysis showed that only ureteral strictures had a negative impact on long-term graft survival (P = .0009) compared to other complications. Death censored graft survival was significantly shorter in kidney recipients managed initially with minimally invasive approach when compared to the recipients with no stricture (P = .001). However, graft survival was not statistically different in patients managed initially with open surgery (P = .47). Ureteral strictures following kidney transplantation appear to be strongly negatively correlated with long-term graft survival. Our analysis suggests that kidney recipients with ureteral stricture should be managed initially with open surgery, with better long-term graft survival.
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| MATERIAL S AND ME THODS
After obtaining institutional review board (IRB) approval, we retrospectively reviewed a prospectively collected institutional database including all adult end stage renal disease (ESRD) patients who underwent primary kidney transplantation between January 2000 and June 2012 at our institution. Data from the electronic medical records was extracted for patients with urological complications occurring within the first year posttransplant. Urological complications included: ureteral stricture, urinary leaks and urinomas, symptomatic vesicoureteral reflux (VUR), lymphoceles causing urinary system dilatation, urinary system dilatations in which any stricture could be shown, and reported kidney or ureter injury during the transplant surgery or procurement. Data on biopsy proven rejection and BK virus infection was also retrieved. Overall and death censored graft survivals, patient survival, and rejection rates were compared between recipients with and without urological complications. Since we were interested in urological complications occurring in the first year, we tracked outcomes from the one-year post-transplant mark and excluded graft losses that occurred less than 1-year post-transplant. All data collection and analysis were performed after IRB approval and statistical analysis was performed using STATA (StataCorp LLC, College Station, TX), associations between proposed risk factors and urological complications were assessed using chi-squared and t-test, and Kaplan-Meier graphs and log-rank tests were used to assess graft and patient survival. A Coxproportional hazards analysis was performed in order to understand factors potentially influencing graft survival and ureteral stricture.
| Surgical technique
The kidney transplant was performed through a standard hypogastric incision. After the preparation of a retroperitoneal operative bed in iliac fossa, the iliac arteries and vein were exposed with the ligation of lymphatic vessels. The kidney graft was placed on either side in the retroperitoneum and anastomosed to the external or common iliac vessels. An extravesical ureteroneocystostomy with a previously described anti-reflux mechanism was routinely performed in all recipients. A double-J ureteral stent was also used routinely in all cases.
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| Kidney recipients with ureteral stricture
A separate analysis was conducted to determine the effect of different primary treatment strategies in patients with ureteral strictures on long-term graft survival. Ureteral stricture was defined as ureteral luminal narrowing or obstruction due to the primary scarring or fibrosis of ureter without external compression. Procedural, operative, and pathology reports were reviewed to determine which patients had clinically significant ureteral stricture, where the lesion or lesions were located, and whether operative surgery or an interventional radiological procedure was chosen as the first treatment modality. We also recorded postoperative estimated glomerular Table 1) . Cases of urological complications were associated more often with recipient male gender, delayed graft function (DGF), and increasing donor age (P < .05).
| Patient and graft survival analysis
In patients with urological complications, we observed a significant decrease in death censored graft survival (P = .003) ( Figure 1 ) and patient survival (P = .001) (data not shown). Among the different types of complications, ureteral stricture, symptomatic VUR of the transplant ureter, lymphoceles, and dilatation of ureter or pelvis without strictures were associated with statistically significantly decreased overall graft survival (P < .05) ( Table 2 ). However, when death censored graft survivals were analyzed, there was no statistically significant difference between the patients with and without urological complications (P = .051) and only ureteral strictures were associated with significantly decreased graft survival (P = .0009).
There was no significant difference in the rate of rejection between patients with and without urological complications (P > .05).
The impact of ureteral stricture and the factors shown to be associated with urological complications on graft survival was also calculated with a Cox-proportional hazards analysis as shown on Table 3 . According to this table, while increasing age of recipient, DGF and ureteral stricture had a statistically significant negative impact on graft survival (P < .05), P value of male gender of the recipient did not reach the level of statistical significance (P = .07).
| Kidney recipients with ureteral strictures
| Demographics
Between 2000 and 2012, 88 (3.8%) patients of 2274 developed a ureteral stricture. Of these 88 patients, 63 were reported to have a ureteral stricture in the first year post-kidney transplantation yielding a stricture rate of 2.8% in our experience. However, upon further examination, only 52 out of the 63 patients were treated at our center.
The remaining 11 patients were excluded as they were either not managed at our facility, were miscoded and upon further chart review had other complications such as lymphocele or urine leak, or did not have clinically significant strictures that required intervention. Of these 52 patients, 7 lost their grafts within the first year after the kidney transplantation and were excluded from the long-term graft survival analysis. Of the remaining 45 patients, whose kidney functioned more than one year, the anatomical distribution of the strictures was as follows:
10 in the proximal third, 6 in mid-third, 21 in distal third of the ureter, and 8 patients were noted to have multiple stricture points. there was a positive association between donor age and ureteral stricture (P = .004) ( Table 5) . 
TA B L E 1 Donor and recipient demographic characteristics
| Patient and graft survival analysis
Of the 45 patients with functioning grafts greater than one year after transplant and verified ureteral strictures, overall and death censored graft survival was significantly lower in kidney recipients with ureteral stricture compared to those without ureteral stricture diagnosis. (P = .0015 and P = .0028, respectively) ( Figure 2 ).
However, patient survival was not significantly different between these groups (P = .11). When the patients were grouped according to the location of, or number of, strictures, we did not observe a significant difference among groups in overall and death censored graft survivals or patient survival (P > .05), though the number of cases in each subcategory were small. Similarly, after stratifying according to time of stricture diagnosis, there was no significant difference in death censored graft and patient survivals amongst recipients with ureteral strictures diagnosed within the first three months after the kidney transplant versus those without strictures (P > .05). However, recipients with strictures diagnosed between 4 and 12 months after transplant showed significantly decreased death censored graft and patient survival compared to recipients without ureteral strictures (P = .0009 and P = .005, respectively).
When evaluating the effect of the initial treatment modality on graft survival, death censored graft survival was significantly decreased in kidney recipients who were initially managed via a minimally invasive approach when compared to the recipients without ureteral strictures (P = .0008) (Figure 3 ). Patient survival comparing these two groups was not statistically significantly different (P = .27). We also found that there was no significant difference between patients with ureteral strictures initially managed via open surgery and patients without ureteral stricture in patient survival (P = .23) and death censored graft survival (P = .47) (Figure 3 ).
There was no significant difference in rejection or BK virus infection rates before the diagnosis of ureteral stricture in both treatment groups (P > .05). However, patients initially managed via a minimally invasive approach were found to have a significantly higher overall incidence of biopsy proven rejection than patients without ureteral strictures (P = .0003) whereas there was no statistical difference between open surgery patients and patients without stricture (P = .5) (Figure 4 ). There was no significant difference in the rate of any type of diagnosed BK virus infection (BK viremia and BK nephropathy together) among the patients with or without ureteral strictures after kidney transplantation (P > .05).
In spite of the differences in graft survivals, the eGFR values at one and five years posttransplant were not statistically different among treatment groups and the patients without ureteral strictures (P < .05) ( Table 6 ). 
| D ISCUSS I ON
The incidence of urological complications after kidney transplantation varies depending on the type of complications included in a given analysis. 3, 14, [17] [18] [19] [20] [21] [22] The majority of urological complications have been reported to occur in the early period after kidney transplantation, 14, 22, 23 thus a low threshold of suspicion is essential to identify these early causes of graft dysfunction. The urological complication incidence of 9.3% cited in our study may be considered high when compared to recent similar studies, 24 however, most of these studies only include ureteral stricture and urinary leaks as urological complications, while our study includes other urological complications such as VUR, lymphocele, dilatation of ureter or pelvis without stricture, and others. If our study only included ureteral strictures and urinary leaks, the total urological complication rate in this large series would be 4%.
Multiple independent risk factors for postoperative urological complications after kidney transplantation necessitating a surgical revision have been identified in the literature. 3, 25 Our analysis shows that male gender of the recipient, DGF, and increasing donor age ureteral dilatation to be the most common primary endourological treatment with a success rate of 58.6% (95% CI 50.1-66.7, n = 133). 41 In our series, the success rate after initial minimally invasive man- TA B L E 6 GFR values at 1-and 5-y posttransplant stratified by treatment strategy of ureteral stricture versus no stricture cases either ureteroureterostomy (UU) or pyeloureterostomy (PU). Only in three patients, ureteroneocystostomy (UNC) was performed after the minimally invasive procedures failed. Thus, comparison of UNC to UU/PU is not possible in our series due to the small numbers. In the literature, there are a few studies reporting higher obstruction rate for UU, but most of the current studies and a large-scale metaanalysis show similar urological complication rates between UNC and UU/PU groups. 24, 45 The need for a native nephrectomy after UU/PU could be questioned, but the incidence of native kidney hydronephrosis requiring native nephrectomy would be expected to be very low in patients on chronic dialysis. Although no increase in morbidity was reported in some of the studies, the answer is not still clear. 24, 46 None of our patients treated initially with open surgical management required native nephrectomy.
Another interesting finding produced from our study was the un- However, contrary to our finding, two retrospective studies with a follow-up period of more than five years showed no worse graft survival than the control group. 30, 47 These conflicting results may be due to differences in study design, types of minimally invasive procedures, and other factors related to the respective patient populations.
The underlying mechanisms for shorter graft survival of patients initially managed with minimally invasive procedures are not clear.
One might suppose, however, that failure to restore unobstructed urine outflow and/or need for multiple instrumentations may be contributing factors to repetitive renal injury, which could ultimately limit functional graft survival. Other underlying contributing factors could include empirically reducing immunosuppressive therapy to manage the urinary tract infections, which are common in this population 34, 40 potentially leading to increased rates of chronic rejection.
Or, recurring urinary tract infections and chronic inflammation may enhance alloreactivity and contribute to rejection episodes through the release of associated molecular patterns, pathogen associated patterns, and through the alterations in alloreactive T cell repertoire. 48, 49 However, these explanations are all in theory with no solid evidence yet.
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Another noteworthy finding from our study was the decreased graft survival of recipients with strictures diagnosed between 4 and 12 months after implantation. We think that since the patient follow-up is less frequent after the first three months, the diagnosis of the ureteral stricture might be delayed. Theoretically, this duration of partial obstruction without intervention might be a factor contributing low graft survival in recipients with strictures diagnosed between 4 and 12 months after transplant.
At many transplant centers, a minimally invasive interventional approach is still the primary strategy to treat ureteral strictures in kidney transplant recipients. However, our data calls this practice into question. Patients with ureteral strictures experienced inferior graft survival if their stricture was first managed by an interventional radiological approach compared to those first managed by surgical revision. Although this was not a randomized prospective trial and therefore has some potential selection bias, and the number of patients was small in each treatment arm, it does merit a reevaluation of the commonly practiced strategy of first tackling ureteral strictures by a percutaneous interventional procedure.
| CON CLUS ION
Ureteral strictures following kidney transplantation appear to be strongly negatively correlated with long-term graft survival.
Although it may be unavoidable at instances, prevention is better than cure. A significant proportion of these early urologic complica- G.E.L. participated in data analysis.
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